ALSO NOTED: GSK buys Canadian vaccine company;FDA committee weighs inhaled insulin; and much more...

> Infection has become a major concern as EPA tests found bacteria levels in the flood waters in and around New Orleans at 10 times the dangerous level. Story (Wall Street Journal sub. req.)

> An FDA advisory committee is expected to rule today on whether or not to approve an inhaled version of insulin made by Sanofi-Aventis and Pfizer. Story

> HIT: IBM said it has developed a new data analysis tool targeting Medicaid fraud. Several counties in upstate New York are testing the software. Release

> A new study by researchers at the University of Michigan confirms that long hours have an impact on residents similar to that of alcohol. Story

> In yet another sign that drug companies see the vaccine market as worthwhile, GlaxoSmithKline has agreed to pay $1.4 billion for Canadian manufacturer ID Biomedical. Story (Wall Street Journal sub. req.)

> HIT: Johns Hopkins says it will consolidate many of its IT systems through a major SAP implementation called HopkinsOne. Story

> HIT: EDS said Oklahoma has agreed to a three-year, $59.1 million extension of its Medicaid Management Information System contract. Release

> A strike scheduled to begin September 13 at nine Sutter Hospitals in the San Francisco Bay area looks like it may indeed happen. Story

And Finally... An HIV-positive man in Utah has filed suit against HealthSouth Provo, a surgery center, for refusing him treatment. Doctors told the man the facility does not treat HIV-positive patients. Story

Post a comment